Login / Signup

Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia.

May GarrettBeverly KnightJorge E CortesMichael W Deininger
Published in: Cancer medicine (2023)
gov identifiers: NCT00574873; NCT02130557; NCT03128411.
Keyphrases
  • chronic myeloid leukemia
  • newly diagnosed
  • drug induced